Satellite Symposium Breakfast at the 2022 RHA Annual Conference
Managing Moderate to Severe CKD-Associated Pruritus In Adult Patients On Hemodialysis - Sponsored by Vifor Pharma
Thursday, October 6
7:00 - 8:00 a.m.
During the Vifor Pharma Breakfast Symposium, we will discuss the challenges associated with CKDaP and KORSUVA™ (difelikefalin) as an option for treatment of moderate-to-severe pruritus associated with chronic kidney disease (CKD-aP) in adults undergoing hemodialysis (HD).
The Vifor Pharma Breakfast Symposium on Thursday morning is not part of the RHA educational program. The program is wholly developed, presented, and sponsored by Vifor Pharma. RHA is not responsible for the content of this session and does not imply sponsorship or endorsement. Promotion, invitations, registration, and onsite logistics for the event will be handled directly with Vifor Pharma.
Note: Breakfast on Thursday morning is available at the Vifor Pharma Breakfast Symposium. RHA will not be providing breakfast on Thursday morning as part of the Conference registration.